Publisher correction: first-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer : the phase 3 TALAPRO-2 trial
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
31 January 2024
|
| In: |
Nature medicine
Year: 2024, Volume: 30, Issue: 5, Pages: 1505 |
| ISSN: | 1546-170X |
| DOI: | 10.1038/s41591-024-02835-9 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41591-024-02835-9 Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41591-024-02835-9 |
| Author Notes: | Karim Fizazi, Arun A. Azad, Nobuaki Matsubara, Joan Carles, Andre P. Fay, Ugo De Giorgi, Jae Young Joung, Peter C.C. Fong, Eric Voog, Robert J. Jones, Neal D. Shore, Curtis Dunshee, Stefanie Zschäbitz, Jan Oldenburg, Dingwei Ye, Xun Lin, Cynthia G. Healy, Nicola Di Santo, A. Douglas Laird, Fabian Zohren & Neeraj Agarwal |
| Item Description: | Gesehen am 19.02.2024 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1546-170X |
| DOI: | 10.1038/s41591-024-02835-9 |